Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Roy J. Vaz"'
Autor:
Isaac Yi Kim, Roy J. Vaz, Naoya Nagaya, Hatem E. Sabaawy, Wun-Jae Kim, Gabriele Cruciani, Jenny Desantis, Kiran Madura, Geun Taek Lee
Publikováno v:
Molecular Cancer Therapeutics. 20:490-499
Although second-line antiandrogen therapy (SAT) is the standard of care in men with castration-resistant prostate cancer (CRPC), resistance inevitably occurs. One major proposed mechanism of resistance to SAT involves the emergence of androgen recept
Publikováno v:
European Journal of Organic Chemistry. 2020:5828-5832
The addition of electron deficient radicals to the C2 position of indoles has been described in the literature as opposed to electrophilic addition at the C3 position. Density functional theory calculations were used to understand the switch in regio
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:3681-3684
Our internal casein kinase 1ε lead inhibitor, compound 1 was partially cleared by the polymorphic cytochrome P450 2D6. CYP2D6 involvement in metabolism implies more extensive clinical trials. We therefore wanted to reduce the contribution to clearan
Publikováno v:
European J Org Chem
The addition of electron deficient radicals to the C2 position of indoles has been described in the literature as opposed to electrophilic addition at the C3 position. Density functional theory calculations were used to understand the switch in regio
Autor:
Nick A. Paras, Daniel G Droege, Takao Ohyama, Jay Conrad, Shimpei Hirano, Roy J. Vaz, Stanley B. Prusiner, Sasaki Koji, Steven H. Olson, Alexander Y Jiu, John W West, Masahiro Inoue, Makoto Hirasawa, Benjamin C Tang, Jean-Marc M Grandjean, Manuel Elepano, Ryo Murakami, Joanne Lee, Masakazu Hirouchi, Atsushi Aoyagi
Publikováno v:
ACS medicinal chemistry letters, vol 11, iss 2
ACS Med Chem Lett
ACS Med Chem Lett
[Image: see text] Tau prions feature in the brains of patients suffering from Alzheimer’s disease and other tauopathies. For the development of therapeutics that target the replication of tau prions, a high-content, fluorescence-based cell assay wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f91271b5afcc886791b89cc2cad0e9
https://escholarship.org/uc/item/4cz02519
https://escholarship.org/uc/item/4cz02519
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:3046-3049
This work describes the rational amelioration of mechanism-based inactivation (MBI) of Cytochrome P450 (CYP) 3A4 in a human hematopoietic prostaglandin D synthase (hH-PGDS) inhibitor (cpd 1). We utilized metabolism reports in order to check if patter
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:446-451
Abuse of the common anti-diarrheal loperamide is associated with QT interval prolongation as well as development of the potentially fatal arrhythmia torsades de pointes. The mechanism underlying this cardiotoxicity is high affinity inhibition of the
Autor:
Roy J. Vaz, Donglai Yang, Hong Shen, Xin Chen, Stephan Reiling, Raymond Kosley, Theresa A. Kuntzweiler, Joseph D. Batchelor, Ying Zhang, Yi Li, Vinolia Chellaraj, Larry R. McLean
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:3194-3196
This work describes the rational amelioration of Cytochrome P450 4/5 (CYP3A4/5) induction through the Pregnane-X Receptor (PXR) pathway in a series of compounds that modulate the metabotropic glutamate Receptor 2 (mGluR2) via an allosteric mechanism.
Publikováno v:
Journal of Biological Chemistry. 290:11041-11051
The chemokine receptors CCR5 and CCR2b share 89% amino acid homology. CCR5 is a co-receptor for HIV and CCR5 antagonists have been investigated as inhibitors of HIV infection. We describe the use of two CCR5 antagonists, Schering-C (SCH-C), which is
With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals wit